Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. - Herr FL; Dascalescu C; Ebner R; Schnitzer ML; Fabritius MP; Schmid-Tannwald C; Zacherl MJ; Wenter V; Unterrainer LM; Brendel M; Holzgreve A; Werner RA; et al. (Theranostics, 2025)